Literature DB >> 23768031

Use of intravenous lipid emulsion in the resuscitation of a patient with cardiovascular collapse after a severe overdose of quetiapine.

Malin Bartos1, Kai Knudsen.   

Abstract

BACKGROUND: Quetiapine is an atypical antipsychotic medication that is increasingly being used in the treatment of psychotic disorders and depression. An overdose of quetiapine is associated with hypotension, sinus tachycardia, and sedation. The clinical effects of its overdose are often mild to moderate, but a severe overdose can cause cardiovascular collapse and death.Intravenous lipid emulsion (ILE) is a proposed treatment for potentially lethal cardiotoxicity after severe overdoses with lipophilic drugs, such as quetiapine, mainly by the sequestration of the lipophilic toxin to an expanded intravascular lipid phase.
OBJECTIVES: To report a case where ILE was successfully used in the resuscitation of a patient with cardiovascular collapse after a severe quetiapine overdose. CASE REPORT: A 42-year-old woman was admitted to the Emergency Department after being found unconscious at home, due to an estimated ingestion of 24 g of quetiapine (Seroquel). She was initially cardiorespiratory stable and unresponsive with a Glasgow Coma Scale of 3. The woman was immediately admitted to the Intensive Care Unit, where her condition quickly deteriorated. She was intubated, due to loss of airway. In addition, a gastric lavage was performed and activated charcoal was administered. The patient presented with cardiovascular collapse refractory to vasopressor treatment and volume resuscitation. ILE bolus followed by continuous infusion was administered. Her blood pressure started increasing 5 min after ILE was initiated and within an hour circulation was stabilized. The patient recovered completely without any residual symptoms, after 3 days in the ICU.
CONCLUSIONS: ILE may potentially be life-saving in cases of severe quetiapine poisoning and should be considered as a treatment for severe cardiovascular instability resulting from quetiapine poisoning refractory to maximum conventional therapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23768031     DOI: 10.3109/15563650.2013.803229

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN: 1556-3650            Impact factor:   4.467


  5 in total

1.  The Repurposing of Anti-Psychotic Drugs, Quetiapine and Olanzapine, as Anti-Cryptococcus Drugs.

Authors:  Adepemi O Ogundeji; Carolina H Pohl; Olihile M Sebolai
Journal:  Front Microbiol       Date:  2017-05-09       Impact factor: 5.640

2.  Intentional Recreational Abuse of Quetiapine Compared to Other Second-generation Antipsychotics.

Authors:  Lauren Klein; Stacey Bangh; Jon B Cole
Journal:  West J Emerg Med       Date:  2016-12-06

3.  Relationship between tracheal intubation and the drugs used by patients with drug overdose due to self-harm.

Authors:  Kazuki Nagashima; Hiroyuki Hosono; Machiko Watanabe
Journal:  J Pharm Health Care Sci       Date:  2022-01-03

Review 4.  Lipemia: causes, interference mechanisms, detection and management.

Authors:  Nora Nikolac
Journal:  Biochem Med (Zagreb)       Date:  2014-02-15       Impact factor: 2.313

5.  Frequency and causes of lipemia interference of clinical chemistry laboratory tests.

Authors:  Sandhya Mainali; Scott R Davis; Matthew D Krasowski
Journal:  Pract Lab Med       Date:  2017-02-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.